PHILADELPHIA--(BUSINESS WIRE)--Jan. 3, 2006--Lannett Company, Inc. (AMEX:LCI), a manufacturer of generic pharmaceuticals, today announced that Arthur P. Bedrosian, currently the company’s president, has also been appointed chief executive officer and director, succeeding William Farber, who remains chairman.
